CA1203241A - 5-(substituted phenyl)hydantoins - Google Patents

5-(substituted phenyl)hydantoins

Info

Publication number
CA1203241A
CA1203241A CA000440069A CA440069A CA1203241A CA 1203241 A CA1203241 A CA 1203241A CA 000440069 A CA000440069 A CA 000440069A CA 440069 A CA440069 A CA 440069A CA 1203241 A CA1203241 A CA 1203241A
Authority
CA
Canada
Prior art keywords
formula
chloro
fluoro
hydrogen
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000440069A
Other languages
English (en)
French (fr)
Inventor
James P. Rizzi
Rodney C. Schnur
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Ltd Great Britain
Original Assignee
Pfizer Ltd Great Britain
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ltd Great Britain filed Critical Pfizer Ltd Great Britain
Application granted granted Critical
Publication of CA1203241A publication Critical patent/CA1203241A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C07D233/76—Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C07D233/76—Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
    • C07D233/78—Radicals substituted by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA000440069A 1982-11-01 1983-10-31 5-(substituted phenyl)hydantoins Expired CA1203241A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/438,199 US4452806A (en) 1982-11-01 1982-11-01 Treating diabetic complications with 5-(substituted phenyl)hydantoins
US438,199 1982-11-01

Publications (1)

Publication Number Publication Date
CA1203241A true CA1203241A (en) 1986-04-15

Family

ID=23739660

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000440069A Expired CA1203241A (en) 1982-11-01 1983-10-31 5-(substituted phenyl)hydantoins

Country Status (13)

Country Link
US (1) US4452806A (2)
JP (1) JPS5998063A (2)
KR (1) KR860001507B1 (2)
CA (1) CA1203241A (2)
DK (1) DK158724C (2)
ES (1) ES8507119A1 (2)
FI (1) FI80265C (2)
GR (1) GR79638B (2)
HU (1) HU191887B (2)
PL (1) PL139646B1 (2)
PT (1) PT77578A (2)
YU (1) YU43556B (2)
ZA (1) ZA838092B (2)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1278413C (zh) 2000-09-25 2006-10-04 揖斐电株式会社 半导体元件及其制造方法、多层印刷布线板及其制造方法
IT1319201B1 (it) * 2000-10-12 2003-09-26 Nicox Sa Farmaci per il diabete.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2814256A1 (de) * 1977-04-05 1978-10-12 Ciba Geigy Ag Schmieroelzusatzstoffe
FR2458546A1 (fr) * 1979-06-07 1981-01-02 Hoechst France Procede de fabrication d'aryl-5 hydantoines racemiques et produits nouveaux en resultant

Also Published As

Publication number Publication date
FI80265B (fi) 1990-01-31
DK499983A (da) 1984-05-02
PT77578A (en) 1983-11-01
YU43556B (en) 1989-08-31
JPH0465832B2 (2) 1992-10-21
ES526841A0 (es) 1985-05-01
DK158724C (da) 1990-11-19
FI833993A0 (fi) 1983-10-31
DK499983D0 (da) 1983-11-01
ZA838092B (en) 1985-06-26
ES8507119A1 (es) 1985-05-01
KR860001507B1 (ko) 1986-09-30
US4452806A (en) 1984-06-05
PL139646B1 (en) 1987-02-28
GR79638B (2) 1984-10-31
DK158724B (da) 1990-07-09
YU216783A (en) 1986-02-28
JPS5998063A (ja) 1984-06-06
FI80265C (fi) 1990-05-10
FI833993A7 (fi) 1984-05-02
KR840006630A (ko) 1984-12-01
HU191887B (en) 1987-04-28
PL244350A1 (en) 1985-02-13

Similar Documents

Publication Publication Date Title
FI62838C (fi) Foerfarande foer framstaellning av den nya farmaceutiskt anvaendbara hoegerroterande isomeren av en asymmetriskt spiro-hydantoinfoerening
DE60312016T2 (de) Cyclohexylsulfon-derivate als gamma-secretase-inhibitoren
US4182769A (en) Anti-inflammatory 1-substituted-4,5-diaryl-2-(substituted-thio) imidazoles and their corresponding sulfoxides and sulfones
CA1125778A (en) Pleuromutilin derivatives, their production and use
US20060094721A9 (en) Sulfonamides as potassium channel blockers
WO1995029904A1 (en) Substituted thiazole sulfonamides as antiglaucoma agents
CA1203241A (en) 5-(substituted phenyl)hydantoins
NO176273B (no) Analogifremgangsmåte for fremstilling av aktive substituerte benzamider
US4284642A (en) 1,3-Diaryl-2-imino-imidazolidines and compositions thereof
EP0228237B1 (en) Substituted thiophene-2-sulfonamide antiglaucoma agents
EP0219429B1 (en) Substituted benzenesulfonamide and antiglaucoma formulations containing them
WO1988007044A1 (en) Timolol derivatives
CA2052544A1 (en) Substituted thieno [2,3-b] [1,4] thiazine-6-sulfonamides as antiglaucoma agents
EP0294994B1 (en) 3-4-Dihydro-2-alkyl-3-oxo-N-aryl-2H-[1]benzothieno[3,2-el]-1,2-thiazine-4-carboxamide-1,1-dioxides
EP0182691B1 (en) Substituted thiophene-2-sulfonamides and their preparation
US3448149A (en) Benzenesulfonyl ureas
WO2005113490A1 (en) Sulfone-containing prodrugs
US3717637A (en) TRIFLUOROMETHYLTHIO SUBSTITUTED DIBENZ [b,f] [1,4] OXAZEPINES
EP0112620B1 (en) 5-(substituted phenyl) hydantoins
CA1195689A (en) Aldose reductase inhibiting 5-(2-alkoxy-3-substituted phenyl) hydantoins
KR870000584B1 (ko) 6-플루오로-4-우레이도크로만-4-카복실산으로부터 6-플루오로-4-크로만온의 재생방법
EP0847996A1 (de) Sulfonamid-substituierte Verbindungen als K-Kanal-Blocker
AU2003259852B2 (en) Sulfonamides as potassium channel blockers
PL152323B1 (en) Method of obtaining novel spiro-heteroazolones
WO1996011901A1 (de) NEUE α,α,α',α'-TETRACHLORDICARBONSÄUREN, VERFAHREN ZU IHRER HERSTELLUNG UND DIESE ENTHALTENDE ARZNEIMITTEL

Legal Events

Date Code Title Description
MKEX Expiry